Where I see patients (2)
Selected research
-
Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.
Diabetes care
-
Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF Syndrome.
bioRxiv : the preprint server for biology
-
A biomimetic five-module chimeric antigen receptor (5MCAR) designed to target and eliminate antigen-specific T cells.
Proceedings of the National Academy of Sciences of the United States of America
Clinical trials
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous F...
Evaluate the effect of inclisiran compared to placebo on reducing LDL-C [percent change] at Day 330
Recruiting
More about this studyStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hype...
Demonstrate superiority of inclisiran compared to placebo in reducing LDL-C [percent change] at Day 330
Recruiting
More about this studyContact me
